ReviewFrontiers in immunology2026

Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report and review of the literature.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.